Evidence map›Paper›PMID 20970123›Full record

ArticleFertility and sterility2011

Inhibition of CD44 N- and O-linked glycosylation decreases endometrial cell lines attachment to peritoneal mesothelial cells.

Allison K Rodgers, Anitha Nair, Peter A Binkley, Rajeshwar Tekmal, Robert S Schenken

Open access · bronzeAbstract read
In one paragraph

Article in Fertility and sterility, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights.International journal of molecular sciences · 2019
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Allison K RodgersDepartment of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio, Texas 78229, USA.
Anitha Nair
Peter A Binkley
Rajeshwar Tekmal
Robert S Schenken
The University of Texas Health Science Center at San Antonio · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
CSF-1 and c-fms and the Early Endometriotic LesionR01HD049637 · NICHD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI TEKMAL, RAJESHWAR R · 2008 to 2010
$968k
Hyaluronan/CD44 and the Early Endometriotic LesionR01HD044135 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI SCHENKEN, ROBERT S · 2003 to 2005
$805k
NCI NIH HHS P30 CA054174NCI NIH HHS P30 CA54174NICHD NIH HHS HD044135NICHD NIH HHS HD049637NICHD NIH HHS R01 HD044135NICHD NIH HHS R01 HD049637
6 · The paper itself

Abstract

The attachment of endometrial epithelial cells (EECs) and endometrial stromal cells (ESCs) to peritoneal mesothelial cells (PMCs) with and without inhibition of N- and O-linked glycosylation, the viability of EECs and ESCs, and the expression of CD44 surface density were evaluated. Inhibition of CD44 N- and O-linked glycosylation by using tunicamycin and/or B-GalNAc statistically significantly inhibited endometrial cell attachment to peritoneal mesothelial cells, suggesting a role in establishment of early endometriotic lesions.

Indexed as

AcetylgalactosamineBenzyl CompoundsCell AdhesionCell LineCell SurvivalDrug Evaluation, PreclinicalEndometriosisEndometriumEnzyme InhibitorsEpithelial CellsEpitheliumFemaleGlycosylationHumansHyaluronan ReceptorsPeritoneal CavityAcetylgalactosaminebenzyl-alpha-N-acetylgalactosamineBenzyl CompoundsCD44 protein, humanEnzyme InhibitorsHyaluronan Receptors

Identifiers

PMID20970123
PMCPMC3026054
OpenAlexW2037281636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.